Batches of Bydureon Recalled in Europe Due to Low Vials

Bristol-Myers Squibb (BMS) and AstraZeneca are recalling 10 batches of the diabetes drug Bydureon in Europe due to under-filled vials. The affected batches were distributed to Romania, the Netherlands, the UK, Ireland, Sweden, Finland, Germany and Spain, BMS said.
Drug GMP Report